X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AJANTA PHARMA with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   MYLAN
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-18
MYLAN
Dec-14
AJANTA PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,8184,042-   
Low Rs1,1062,848-   
Sales per share (Unadj.) Rs239.51,383.8-  
Earnings per share (Unadj.) Rs52.8166.7-  
Cash flow per share (Unadj.) Rs59.5268.3-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs230.0687.9-  
Shares outstanding (eoy) m88.77378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x6.12.5 245.2%   
Avg P/E ratio x27.720.7 134.0%  
P/CF ratio (eoy) x24.612.8 191.4%  
Price / Book Value ratio x6.45.0 126.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m129,7821,303,581 10.0%   
No. of employees `0006.825.0 27.2%   
Total wages/salary Rs m3,7650-   
Avg. sales/employee Rs Th3,128.420,942.8 14.9%   
Avg. wages/employee Rs Th554.00-   
Avg. net profit/employee Rs Th689.72,522.9 27.3%   
INCOME DATA
Net Sales Rs m21,258523,570 4.1%  
Other income Rs m242-3,052 -7.9%   
Total revenues Rs m21,499520,519 4.1%   
Gross profit Rs m6,584130,214 5.1%  
Depreciation Rs m59638,454 1.5%   
Interest Rs m422,584 0.0%   
Profit before tax Rs m6,22666,125 9.4%   
Minority Interest Rs m0-271 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5392,781 55.4%   
Profit after tax Rs m4,68663,073 7.4%  
Gross profit margin %31.024.9 124.5%  
Effective tax rate %24.74.2 587.9%   
Net profit margin %22.012.0 183.0%  
BALANCE SHEET DATA
Current assets Rs m12,236460,288 2.7%   
Current liabilities Rs m3,461359,853 1.0%   
Net working cap to sales %41.319.2 215.2%  
Current ratio x3.51.3 276.4%  
Inventory Days Days6078 77.1%  
Debtors Days Days84107 78.8%  
Net fixed assets Rs m11,140121,127 9.2%   
Share capital Rs m17718,515 1.0%   
"Free" reserves Rs m20,2370-   
Net worth Rs m20,414260,266 7.8%   
Long term debt Rs m10388,812 0.0%   
Total assets Rs m24,4861,048,328 2.3%  
Interest coverage x1,519.43.9 38,682.3%   
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x0.90.5 173.8%   
Return on assets %19.28.2 234.4%  
Return on equity %23.024.2 94.7%  
Return on capital %30.513.6 223.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,0520-   
CASH FLOW
From Operations Rs m2,85468,824 4.1%  
From Investments Rs m-2,604-54,276 4.8%  
From Financial Activity Rs m-2-18,135 0.0%  
Net Cashflow Rs m248-3,588 -6.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 67.82 Rs / USD

Compare AJANTA PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: ALEMBIC PHARMA  TTK HEALTHCARE  STRIDES SHASUN LTD  WYETH LTD  CIPLA  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jun 22, 2018 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - FDC LTD. COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS